Estee Lauder Q4 Earnings Beat Estimates, Sales Down 12% Y/Y

Estee Lauder (EL) reported fiscal Q4 2025 results that beat adjusted earnings and sales estimates, yet both metrics significantly declined year-over-year by 85% and 12% respectively, primarily due to weakness in Asia travel retail and broad category softness, excluding fragrance. While adjusted gross margin improved due to its Profit Recovery and Growth Plan (PRGP), the company posted a larger operating loss. EL anticipates a return to sales growth of 2-5% and adjusted EPS growth of 26-39% in fiscal 2026, driven by the ongoing PRGP, a comprehensive restructuring initiative expected to yield significant annual benefits and restore double-digit operating margins by fiscal 2027.

Analysis

Estee Lauder's fiscal Q4 2025 results present a narrative of severe current-period weakness offset by a forward-looking restructuring plan. While the company surpassed consensus estimates with quarterly net sales of $3.41 billion and adjusted EPS of 9 cents, these figures represent substantial year-over-year declines of 12% and 85%, respectively. The top-line pressure was widespread, with organic sales falling 13% due to softness across all geographic regions, most acutely in EMEA (-22%), and in major product categories like Skin Care (-16%) and Makeup (-11%). The primary driver for this underperformance was the persistent challenge in the Asia travel retail business. A key bright spot was the Fragrance division, which grew 4% on the strength of its luxury brands, Le Labo and Jo Malone, indicating resilient demand in the premium segment. Profitability metrics reflect this difficult environment, with adjusted operating income down 61%, although the adjusted gross margin edged up 10 basis points to 71.9%, an early positive signal from the company's Profit Recovery and Growth Plan (PRGP). The investment case now pivots to this PRGP, a multi-year initiative expected to generate $800 million to $1 billion in annual gross benefits by fiscal 2027. Management's fiscal 2026 guidance, which projects a return to 2-5% sales growth and a 26-39% increase in adjusted EPS, signals confidence in this turnaround, though the near-term Q1 outlook for flat to slightly negative organic sales suggests a gradual recovery.

Key Decisions for Investors

• The primary investment thesis for Estee Lauder is now a turnaround story heavily dependent on the execution of its Profit Recovery and Growth Plan; investors should monitor progress against the stated cost savings and margin restoration targets, given the stock's recent 37.4% appreciation has likely priced in significant success.
• Closely track performance indicators for the Asia travel retail channel, as a recovery in this specific area is a critical catalyst for the core Skin Care and Makeup segments to rebound from their double-digit declines.
• Consider the bifurcation in performance between the struggling mass-market lines and the outperforming luxury fragrance brands, which may signal a long-term shift in the company's growth drivers.
• While the fiscal 2026 EPS growth guidance of 26-39% is strong, weigh it against the muted Q1 forecast and the execution risk of a multi-year restructuring plan before initiating or adding to a position.